13C NMR (400MHz, DMSO-d6): δ 158.3, 143.4, 142.1, 135.8, 129.8, 127.8, 122.1, 115.9, 88.6,
66.7, 64.3, 62.0, 58.2, 53.5, 44.7, 36.9, 35.4, 29.2 ppm. HRMS (ESI-TOF) m/z: [M+H]+ Calcd
for C25H34N5O7S2 580.18; Found 580.19. Anal. Calcd for C25H33N5O7S2: C, 51.80; H, 5.74; N,
12.08; S, 11.06; F, 3. Found: C, 51.64; H, 5.67; N, 11.99; S, 10.91 or compound 4-2 (X =
C6H4CH3-p) (white solid, yield 71%) 1H NMR (400MHz, DMSO-d6): δ 8.60 (1H, s), 7.51 (2H,
d), 7.39 (2H, d), 7.00 (2H, d), 4.36 (2H, s), 4.20 (2H, t), 3.98 (2H, t), 3.54 (4H, m), 3.50 (2H, s),
2.75 (3H, s), 2.33~2.30 (6H, m), 2.95 (2H, m) ppm. 13C NMR (400MHz, DMSO-d6): δ 158.6,
145.3, 144.0, 142.8, 135.4, 130.6, 130.4, 129.8, 128.0, 127.8, 125.8, 122.6, 122.0, 115.1, 68.0,
66.6, 64.0, 62.0, 53.5, 45.3, 35.4, 28.5, 21.5 ppm. HRMS (ESI-TOF) m/z: [M+H]+ Calcd for
C31H38N5O7S2 656.21; Found 656.22. Anal. Calcd for C31H37N5O7S2: C, 56.78; H, 5.69; N,
10.68; S, 9.78. Found: C, 56.48; H, 5.59; N, 10.48; S, 9.80. or compound 4-3 (X = C6H4NO2-p)
(yellow solid, yield 74%) 1H NMR (400MHz, DMSO-d6): δ 8.57 (1H, s), 8.31 (2H, d), 8.17 (2H,
d), 7.75 (2H, d), 7.68 (2H, d), 7.51 (2H, d), 6.95 (2H, d), 4.36~4.34 (4H, m), 3.95 (2H, t),
3.54~3.51(6H, m), 2.75 (3H, s), 2.31 (3H, br), 2.10 (2H, m) ppm. 13C NMR (400MHz, DMSO-
d6): δ 158.0, 150.4, 142.3, 140.0, 135.6, 130.0, 129.3, 127.3, 126.9, 124.9, 123.0, 122.1, 121.3,
115.1, 68.8, 66.1, 63.2, 61.6, 53.1, 44.9, 35.0, 27.9 ppm. HRMS (ESI-TOF) m/z: [M+H]+ Calcd
for C30H35N6O9S2 687.18; Found 687.19. Anal. Calcd for C30H34N6O9S2: C, 52.47; H, 4.99; N,
12.24; S, 9.34. Found: C, 52.17; H, 5.00; N, 12.00; S, 9.41.
Synthesis of Compound 5. To a solution of compound 4-1 (100 mg, 0.173 mmol) in tert-
butanol (2 mL) was added Cesium fluoride (131 mg, 5.0 eqv.) and refluxed the reaction mixture
for 3 h. After the completion of the reaction, the reaction solvent was removed by rotary
evaporation. The residue was dissolved in DCM and washed with water, brine, and dried over
MgSO4 and concentrated. The crude product was purified by flash column chromatography,
eluting with DCM/methanol (10:1, v/v). The purified compound was obtained as a white powder.
(44 mg, yield 51%). 1H NMR (400MHz, DMSO-d6): δ 8.59 (1H, s), 7.76~7.72 (4H, m), 7.49
(2H, d), 7.14 (2H, d), 4.69 (1H, t), 4.57 (1H, t), 4.36 (2H, s), 4.15 (2H, t), 3.53 (4H, br), 3.49
(2H, s), 2.75 (3H, s), 2.30 (4H, br), 2.14 (2H, m) ppm. 13C NMR (400MHz, DMSO-d6): δ 158.4,
143.5, 142.3, 135.4, 130.0, 129.3, 127.3, 122.2, 212.6, 115.4, 80.8 (1JC-F = 643 Hz), 66.1, 64.0
(3JC-F = 2.4 Hz), 61.6, 53.1, 44.9, 35.0, 29.6 (2JC-F = 26 Hz) ppm. 19F NMR (300MHz, CD3Cl): δ
7.53 (1F, m). HRMS (ESI-TOF) m/z: [M+H]+ Calcd for C24H31FN5O4S 504.20; Found 504.21.
Anal. Calcd for C24H30FN5O4S: C, 57.24; H, 6.00; N, 13.91; S, 6.37; F, 3.77. Found: C, 57.07;
H, 5.88; N, 13.99; S, 6.46; F, 3.67.
1.5. Radiosynthesis (Synthesis of Compound [18F]5)
No-carrier-added [18F]F- was obtained through the nuclear reaction 18O(p, n)18F by irradiation of
18O-enriched water. After the delivery of [18F]F- from the cyclotron, the radioactivity was passed
through an anion exchange resin cartridge to trap [18F]F-. [18F]F- was then eluted with a
potassium carbonate solution into a vessel containing Kryptofix 2,2,2 (K222) and the mixture was
dried by azeotropic distillation with acetonitrile. Compound 4 (4-1 or 4-2 or 4-3) in anhydrous
acetonitrile was added to the dried K222/K[18F]F- and the mixture was heated at 120 ˚C for 30
8